About US
Contact us
-
Shanghai ChemPartner signs outsource research service agreement with Shenogen PharmaShangPharma Corporation (NYSE: SHP) ("ShangPharma" or the "Company"), a leading China-based pharmaceutical and biotechnology research and development outsourcing company, today announced that its whol2011/3/17
-
Pharma Firms Continue to Supply Aid to Quake-Stricken JapanPharmaceutical companies are continuing to provide aid and support for victims of the tsunami and 9.0-magnitude earthquake that struck Japan last week. Abbott is providing $3m through its philanth2011/3/17
-
GAO: Prescription Drugs: Trends in Usual and Customary Prices for Commonly Used DrugsWASHINGTON, March 14, 2011- Prescription drug spending in 2009 totaled approximately $250 billion, of which $78 billion--or about 31 percent--was spent by the federal government. Prescription drug spe2011/3/16
-
Japan Hands Out Cancer Drugs as Radiation Risk GrowsThe Japanese Government is handing out iodine pills to prevent the risk of thyroid cancer, as radioactive steam spews from nuclear reactors following a massive earthquake and subsequent explosions at2011/3/16
-
EvaluatePharma data shows poor R&D productivity measures both in quality, quantityPharmaceutical R&D productivity is consistently undercounted. Most reports fail to fully count the number of new drugs that reach the market, missing out on billions of dollars of sales generated2011/3/15
-
Japan's Drug Firms Donate Aid to Quake VictimsJapan's pharmaceutical companies have donated medical supplies and millions of dollars in funding for victims of the 9.0 magnitude earthquake that struck the country on Friday. Takeda Pharmaceutica2011/3/15
-
Scale up of solid dosage forms symposium By GEA Pharma Systems and EvonikRöhm GmbH.·Only very few people truly understand coating processes – Prof. R. Turton is one of those few. ·Only very few companies have real experience with Real Time Release – Merck is among those. ·Me2011/3/14
-
World Pharma Manufacturing Summit 2011Shanghai China March 14-16 Facing intense competition, dwindling margin and growth slowdown, the world pharmaceutical industry spares no effort to reduce manufacturing cost and seek new growing m2011/3/10
-
Pfizer Rheumatoid Arthritis Drug Meets Primary EndpointPfizer has reported that tofacitinib, an investigational oral JAK inhibitor being evaluated in moderate-to-severe rheumatoid arthritis, has met the primary endpoints of a Phase III study. The drug2011/3/10
-
European Agency Creates First Reference Material for NanoparticleAlso initiates a reference library for nanomaterials A European standards organization has produced the first reference material for a nanoparticle and has launched a repository for reference nanom2011/3/9